RCM
DVAX

Rotella Capital Management’s Dynavax Technologies DVAX Stock Holding History

Rotella Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,670
Closed -$38K – 383
2014
Q3 		$38K Sell
2,670
-1,350
-34% -$19.5K 0.04% 265
2014
Q2 		$64K Buy
4,020
+1,120
+39% +$16.9K 0.05% 287
2014
Q1 		$52K Buy
+2,900
New +$53.8K 0.06% 169

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Rotella Capital Management's DVAX Position: Q4 2014 in Review

Rotella Capital Management sold out of Dynavax Technologies (DVAX) in Q4 2014, closing a stake of 2,670 shares — an estimated $38K sold.

Rotella Capital Management first reported a position in DVAX in Q1 2014 and held it in 3 quarters. The position peaked at $64K in Q2 2014. 84 funds tracked by Wall St. Rank hold DVAX as of Q4 2014.

  • Rotella Capital Management reported no remaining Dynavax Technologies position as of Q4 2014 after selling out during the quarter.
  • Rotella Capital Management sold 2,670 Dynavax Technologies shares in Q4 2014, an estimated $38K.
  • Rotella Capital Management first reported a position in Dynavax Technologies in Q1 2014 and held it in 3 quarters.
  • Rotella Capital Management's Dynavax Technologies position peaked at $64K in Q2 2014.
  • 84 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2014.

Based on Rotella Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.